Essent Group LTD Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
FMR LLC and Abigail P. Johnson have filed a Schedule 13G, reporting beneficial ownership of 2,915,486.11 shares of Essent Group Ltd common stock, representing 3.2% of the class.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 7.91% in Essent Group Ltd, holding over 7.4 million shares.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5.1% of Essent Group Ltd's common stock as of March 31, 2026.
NYSE
The Vanguard Group has amended its Schedule 13G for Essent Group Ltd, reporting 0% beneficial ownership following an internal realignment.
NYSE
Capital World Investors has filed an amended Schedule 13G, reporting a 4.9% beneficial ownership stake in Essent Group Ltd. as of December 31, 2025.
NYSE
Capital World Investors has reported a 5.1% beneficial ownership stake in Essent Group Ltd.'s common stock, totaling 5,008,348 shares.
NYSE
FMR LLC and Abigail P. Johnson have filed an Amendment No. 9 to Schedule 13G, reporting a beneficial ownership of 5.7% of Essent Group Ltd.'s common stock as of March 31, 2025.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting a beneficial ownership of 11.76% of Essent Group Ltd.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 12.3% beneficial ownership stake in Essent Group Ltd.'s common stock as of March 31, 2025.
NYSE
Dimensional Fund Advisors LP has filed a Schedule 13G, reporting a 5.2% beneficial ownership stake in Essent Group Ltd.'s common stock, held for investment purposes in the ordinary course of business.
NYSE
Capital World Investors, a division of Capital Research and Management Company, has reported a 4.7% passive beneficial ownership stake in Essent Group Ltd. as of December 31, 2024.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 13.5% beneficial ownership stake in Essent Group Ltd. as of December 31, 2024.